Camargo Pharmaceutical Services, a global drug development strategist specialising in the 505(b)(2) approval pathway, has appointed Marc Wiles as Vice President, Scientific and Regulatory Affairs, and Suzanne Beck as Director, Contracts and Legal Projects.
With more than 20 years of experience in drug development, Wiles brings extensive technical and regulatory expertise to Camargo in assessing, developing and registering therapeutic products.
Before joining Camargo, Wiles was General Manager and Regulatory Affairs Scientific Advisor at NDA Regulatory Science in the UK, where he was responsible for expanding the company’s US operations. He was also Director of Regulatory Affairs (Non-clinical and Clinical) and General Manager at ERA Consulting and Senior Vice President of Operations at ProImmune.
Suzanne Beck
Beck brings legal and regulatory experience to Camargo having been an attorney for more than 15 years, including 10 years as a pharmaceutical document review attorney working across all phases of product development as well as pre- and post-marketing and FDA regulatory filings.